Two new phosphonate compounds (NH 4 ) 2 M 2 (hedpH) 2 (M = Co, 1; Fe, 2 ), where hedp is 1-hydroxyethylidenediphosphonate [CH 3 C(OH)(PO 3 ) 2 ], have been synthesized under hydrothermal conditions at 140 °C. Crystal data: 1, triclinic, P1̄, a = 5.4635(13) Å, b = 7.7205(18) Å, c = 9.976(2) Å, α = 71.198(4)°, β = 82.385(4)°, γ = 87.920(5)°, V = 394.82(16) Å 3, Z = 1; 2, triclinic, P1̄, a = 5.5191(12) Å, b = 7.7183(16) Å, c = 10.051(2) Å, α = 71.551(4)°, β = 82.552(4)°, γ = 87.627(4)°, V = 402.74(15) Å 3, Z = 1. The compounds are isomorphous; all contain anionic double chains of {M 2 (hedpH) 2 } n 2 n -, composed of {MO 6 } octahedra and {CPO 3 } tetrahedra. The double chain can be viewed as a ladder within which dimers of {M 2 (μ−O) 2 } (rung) are separated by O−P−O bridges (rail). Very strong hydrogen bonds exist between the neighboring chains, hence forming a layer in the ab plane. The NH 4 + counterions occupy the cavities within the layer. These layers are further connected by hydrogen bonds to form a three-dimensional network. The temperature-dependent magnetic susceptibility measurements show dominant antiferromagnetic interactions in both compounds, mediated through the μ−O and/or O−P−O bridges between the metal centers. The field dependent magnetization reveals that both experience field-induced magnetic transitions at very low temperatures. The critical fields at 1.9 K are ca. 35 kOe for 1 and 40 kOe for 2, respectively.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: